Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P02794 (ferritin)
 17,525 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Metal-based coordination compounds, including the well-known cytostatic drug cisplatin, are widely used in the anticancer therapy. Generally, they exhibit high cytotoxicity not only towards malignant cells, but also towards non-malignant cells, which represents main problem of their clinical use. Herein, we describe the synthesis, characterization and biological testing of three trinuclear nickel(II) coordination compounds. Central nickel atoms are bridged by trithiocyanurate anion and coordinated by triamine and bis-benzimidazoles, respectively. To delineate a potential usage in anticancer therapy, we encapsulated the most cytotoxic complex into biomacromolecular protein cage apoferritin (FRT), forming FRTNi. FRT encapsulation markedly decreased the hemotoxicity of free Ni compounds. Despite FRTNi can be internalized through passive targeting by enhanced permeability and retention effect, we further introduced active targeting utilizing folate receptor (FR) via folic acid (FA)-modified FRT (FRTNiFA). Using breast cancer cell lines T-47D (FR+), MCF-7 (FR-) and non-malignant mammary gland derived cell line HBL-100 (FR-), we show pronounced FR-dependent internalization of FRTNiFA. Overall, we demonstrate that the FRT macromolecular nanocarrier provides a very low off-target toxicity, which could enable the use of highly toxic Ni compounds in cancer nanomedicine.
 ...
PMID:Folic acid-mediated re-shuttling of ferritin receptor specificity towards a selective delivery of highly cytotoxic nickel(II) coordination compounds. 3060 47

Metal-organic frameworks (MOFs) hold great promise for numerous applications. However, proteins, carriers of biological functions in living systems, have not yet been fully explored as building blocks for the construction of MOFs. This work presents a strategy for the fabrication of binary MOFs. Considering octahedral ferritin symmetry, four His2 (His-His) motifs were first incorporated into the exterior surface of a ferritin nanocage near each C4 channel, yielding protein linkers with multiple metal-binding sites (bisH-SF). Secondly, by adding nickel ions to bisH-SF solutions triggers the self-assembly of ferritin nanocages into a porous 3D crystalline MOF with designed protein lattice, where two adjacent ferritin molecules along the C4 symmetry axes are bridged by four dinuclear or tetranuclear nickel clusters depending on Ni2+ concentration. This work provides a simple approach for precise control over a binary protein-metal crystalline framework, and the resulting MOFs exhibited inherent ferroxidase activity and peroxidase-like catalytic activity.
 ...
PMID:Structural Insight into Binary Protein Metal-Organic Frameworks with Ferritin Nanocages as Linkers and Nickel Clusters as Nodes. 3182 May

In this work, nano-inspired nickel oxide nanoparticles (NiO) and polythiophene (Pth) modified bioanode was prepared for biofuel cell applications. The chemically prepared nickel oxide nanoparticles and its composite with polythiophene were characterized for elemental composition and microscopic characterization while using scanning electron microscopy. The electrochemical characterizations of polythiophene@NiO composite, biocompatible mediator ferritin (Frt) and glucose oxidase (GOx) catalyst modified glassy carbon (GC) electrode were carried out using cyclic voltammetry (CV), linear sweep voltammetry (LSV), and charge-discharge studies. The current density of Pth@NiO/Frt/GOx bioanode was found to be 5.4 mA/cm2. The bioanode exhibited a good bio-electrocatalytic activity towards the oxidation of the glucose. The experimental studies of the bioanode are justifying its employment in biofuel cells. This will cater a platform for the generation of sustainable energy for low temperature devices.
 ...
PMID:Application of Electrically Conducting Nanocomposite Material Polythiophene@NiO/Frt/GOx as Anode for Enzymatic Biofuel Cells. 3229 Jun 40


<< Previous 1 2 3 4